Primary Care POC Diagnostics Market Growth & Trends
The global primary care POC diagnostics market size is expected to reach USD 26.08 billion by 2030, registering a 2.8% CAGR during the forecast period. Flexible and forward-thinking core molecular labs have been embracing and supporting the use of POC tests to move screening of many common targets to hospital receiving rooms and physicians’ offices.
As per a study conducted by the American Journal of Clinical Pathology in 2014, it was found that POC testing improved clinical operations for manufacturers by reducing follow-up calls and letters of patients by 85.0% and 89.0%, respectively, and reducing their follow-up visits by 61.0%. It was also observed that the number of tests ordered decreased by 21.0%.
Furthermore, rise in the number of tests receiving a waived status under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) is anticipated to aid market growth. Researchers and manufacturers are increasingly recommending these tests owing to cost reduction of about USD 12-15 per patient and reduction in follow up tests by about 50.0%. However, there is a massive overlap between different methods and their areas of usage. For instance, panels to measure glucose and quick international normalized ratio tests were originally meant for self-testing but are now used in hospitals and primary settings instead.
Primary Care POC Diagnostics Market Report Highlights
- The cancer markers segment is expected to register the fastest CAGR during the forecast period. The rising cancer incidences, increased demand for screening cancer, and technological advancements are driving the segment’s growth.
- Increase in out-patient practices for lipid testing as part of a routine checkup is expected to positively enhance the adoption rate of lipid testing in the market, giving it a prominent spot in the overall market by product
- In terms of end use, while collaborative research for advanced and more accurate POC testing kits by research institutes and biotech firms is likely to facilitate the physicians’ office segment, government initiatives and projects to extend primary care facilities will boost the non-practice clinics segment
- The North America primary care POC diagnostics market is more developed compared to the rest of the world. The regional segment is fueled by availability of several innovative and advanced POC diagnostic products and growing awareness and demand for point-of-care diagnostics in primary home healthcare and assisted healthcare
- The U.S. market is witnessing a shift toward increasing patient involvement in home care, home-based tests, and monitoring instruments. In addition, digitalization, EHR, telemedicine, and web-enabled solutions of monitoring data are gaining pace in U.S., thereby driving its growth
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Primary Care POC Diagnostics Market Variables, Trends, & Scope
Chapter 4. Primary Care POC Diagnostics Market: Product Estimates & Trend Analysis
Chapter 5. Primary Care POC Diagnostics Market: End Use Estimates & Trend Analysis
Chapter 6. Primary Care POC Diagnostics Market: Regional Estimates & Trend Analysis
Chapter 7. Competitive Landscape
Companies Mentioned
- F Hoffmann-La Roche Ltd.
- Danaher
- Abbott
- Siemens Healthineers
- BIOMÉRIEUX
- QIAGEN
- Nova Biomedical
- Johnson & Johnson Services, Inc.
- OraSure Technologies, Inc.
- BD
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 100 |
| Published | August 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 21.44 Billion |
| Forecasted Market Value ( USD | $ 26.08 Billion |
| Compound Annual Growth Rate | 2.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
